Endurant Capital Management LP acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 22,088 shares of the medical instruments supplier’s stock, valued at approximately $703,000. Other institutional investors and hedge […]
Endurant Capital Management LP raised its stake in shares of Insmed Incorporated (NASDAQ:INSM – Get Rating) by 125.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 243,122 shares of the biopharmaceutical company’s stock after acquiring an additional 135,409 shares during the quarter. Insmed makes […]
Endurant Capital Management LP decreased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 42.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,357 shares of the biotechnology company’s stock after selling 61,017 shares during the period. BioMarin Pharmaceutical comprises about […]
Endurant Capital Management LP purchased a new stake in shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 136,382 shares of the company’s stock, valued at approximately $1,125,000. Other hedge funds have […]
Endurant Capital Management LP bought a new position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 28,187 shares of the biotechnology company’s stock, valued at approximately $1,143,000. Several other large investors have […]